3 Stocks I Plan to Hold for the Next 20 Years [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
holding period applied only to "outstanding businesses with outstanding managements." Since I don't expect to be alive and kicking forever, though, I wouldn't go quite as far as Buffett. However, I can think of at least three stocks that I plan to hold for the next 20 years. Will AI create the world's first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. 1. AbbVie AbbVie (NYSE: ABBV) markets a long lineup of medicines for treating autoimmune diseases, cancer, migraines, and more. Twelve of the company's drugs generated at least $1 billion in sales last year. I suspect that most of those products won't rank among AbbVie's biggest winners 20 years from now. Patent expirations open the door for biosimilar and generic competition. Scientific advances will likely lead to more effective treatments over the next couple
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) Is One Of The Major Stock To Buy According To Wall Street [Yahoo! Finance]Yahoo! Finance
- The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond [Yahoo! Finance]Yahoo! Finance
- Only 3 Dividend Kings Passed This Brutal Screen. They Could Pay You Well for Years to Come. [Yahoo! Finance]Yahoo! Finance
- Why AbbVie Is a No-Brainer Stock to Buy on the Dip [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 4/3/26 - Form 8-K
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABBV's page on the SEC website